Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021019
Company: GLAXOSMITHKLINE

Products on NDA 21019

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
COMPAZINE	PROCHLORPERAZINE MALEATE	EQ 10MG BASE	CAPSULE, EXTENDED RELEASE;ORAL	Discontinued	None	No	No
COMPAZINE	PROCHLORPERAZINE MALEATE	EQ 15MG BASE	CAPSULE, EXTENDED RELEASE;ORAL	Discontinued	None	No	No

Labels for NDA 021019

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
10/06/1999	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21019A_Compazine_appltrs_prntlbl.pdf